AtriCure announced that the first patient was treated in the Left Atrial Appendage Exclusion for Stroke Prevention, or LeAAPS, clinical trial. The patient was treated by U.S. co-principal investigator Marc Gerdisch at Franciscan St. Francis Heart Center in Indianapolis, Indiana.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ATRC: